Understanding Compounded GLP-1 options
Compounding combines or alters ingredients to meet a specific patient need when legally permitted and clinically appropriate. A compounded preparation is not an FDA-approved medication or an interchangeable generic version of a branded product.
How it works
The intended action depends on the prescribed ingredient and formulation. Evidence for an FDA-approved product cannot establish the effectiveness, quality or safety of a compounded preparation, even when ingredient names sound similar.
How it is administered
Administration, concentration, measuring equipment and storage depend on the exact preparation. Your prescriber and dispensing pharmacy must provide specific instructions. Never convert a branded product’s dose or syringe units yourself; dosing errors can cause serious harm.
Clinical research & results
Compounded medications do not undergo FDA premarket review for safety, effectiveness or quality. No branded-drug trial percentage is assigned here, and no weight-loss calculator is provided for these preparations. FDA-approved options should be considered when they can meet the patient’s needs.
These are separate trials, not a direct comparison between medicines. Study averages do not establish which medicine is best for you.
FDA guidance on unapproved GLP-1 drugsCommon side effects
Risks depend on the ingredient and preparation and may include digestive symptoms, dehydration, dosing errors, contamination or inconsistent strength. Lack of FDA approval is not evidence that a preparation has been shown safe.
Safety & important considerations
- Compounded products are not FDA-approved. FDA does not verify their safety, effectiveness or quality before marketing. They must not be described as equivalent to Wegovy, Zepbound or other approved medicines.
- Availability is restricted by federal and state compounding law; routine copies of commercially available drugs are generally restricted. A clinical evaluation and legally valid patient-specific need are required; supply is not guaranteed.
- FDA has warned about dosing errors, unapproved GLP-1 drugs and semaglutide salt forms such as semaglutide sodium or acetate, which differ from the active ingredient in approved products. Ask about the ingredient, licensed pharmacy, concentration, handling and follow-up.
- The neutral vial image is editorial imagery, not a photograph of a dispensed Lexa preparation. Your clinician and pharmacy must explain the actual product and its risks.
This is a summary, not a complete list of risks or instructions. Read the full prescribing information and Medication Guide and speak with your clinician.
Read official safety informationMore about Compounded GLP-1 options
Why aren’t compounded medicines FDA-approved?
They are prepared under compounding rules for specific needs, rather than the FDA new-drug approval pathway. They do not receive the same premarket assessment of safety, effectiveness and manufacturing quality.
Can I expect the same results as a branded medication?
No. Clinical-trial results for approved branded products cannot be assumed for a compounded preparation. There is no trial-based estimate on this page.
Who can receive a compounded option?
A clinician must evaluate the individual need and whether compounding is lawful and appropriate. A request or membership does not establish eligibility or availability.
